NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
23.44
-0.55 (-2.27%)
At close: Jul 24, 2025, 4:00 PM
23.39
-0.04 (-0.19%)
After-hours: Jul 24, 2025, 5:08 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.63 billion as of July 24, 2025. Its market cap has increased by 46.19% in one year.
Market Cap
2.63B
Enterprise Value
1.82B
1-Year Change
46.19%
Ranking
Category
Stock Price
$23.44
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.63B, an increase of 1,603.51%. That is a compound annual growth rate of 88.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2025 | 2.69B | -2.15% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | 154.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 702.26B |
| Johnson & Johnson | 403.64B |
| AbbVie | 331.36B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 259.73B |
| Novartis AG | 224.80B |
| Abbott Laboratories | 217.81B |
| AstraZeneca | 216.82B |